tiprankstipranks
Trending News
More News >
Grace Therapeutics (GRCE)
NASDAQ:GRCE
US Market

Grace Therapeutics (GRCE) Financial Statements

Compare
1,172 Followers

Grace Therapeutics Financial Overview

Grace Therapeutics's market cap is currently $57.72M. The company's EPS TTM is $-0.06; its P/E ratio is -6.50; Grace Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 196.00K
Gross ProfitC$ 0.00C$ -11.00KC$ 0.00C$ 0.00C$ 120.00K
Operating IncomeC$ -16.68MC$ -11.31MC$ -52.16MC$ -15.59MC$ -16.42M
EBITDAC$ -16.67MC$ -14.62MC$ -18.12MC$ -15.34MC$ -9.79M
Net IncomeC$ -9.57MC$ -12.85MC$ -42.43MC$ -9.82MC$ -19.68M
Balance Sheet
Cash & Short-Term InvestmentsC$ 22.13MC$ 23.00MC$ 27.89MC$ 43.66MC$ 60.73M
Total AssetsC$ 71.99MC$ 73.30MC$ 79.12MC$ 128.62MC$ 62.46M
Total DebtC$ 0.00C$ 0.00C$ 485.00KC$ 295.00KC$ 86.00K
Net DebtC$ -22.13MC$ -23.00MC$ -27.39MC$ -30.04MC$ -50.86M
Total LiabilitiesC$ 5.38MC$ 11.56MC$ 11.17MC$ 20.35MC$ 6.80M
Stockholders' EquityC$ 66.61MC$ 61.74MC$ 67.95MC$ 108.27MC$ 55.66M
Cash Flow
Free Cash FlowC$ -14.90MC$ -12.36MC$ -15.93MC$ -17.23MC$ -14.39M
Operating Cash FlowC$ -14.90MC$ -12.33MC$ -15.91MC$ -17.23MC$ -14.32M
Investing Cash FlowC$ 0.00C$ 104.00KC$ 13.15MC$ -3.52MC$ -9.86M
Financing Cash FlowC$ 14.03MC$ 7.36MC$ 304.00KC$ 0.00C$ 59.49M
Currency in CAD

Grace Therapeutics Earnings and Revenue History

Grace Therapeutics Debt to Assets

Grace Therapeutics Cash Flow

Grace Therapeutics Forecast EPS vs Actual EPS